148 related articles for article (PubMed ID: 24993654)
1. [Delays in treatment of breast cancer: experience of an expert center of the Assistance Publique-Hôpitaux de Paris (AP-HP)].
Revaux A; Laas E; Chopier J; Thomassin-Naggara I; Touboul E; Antoine M; Gligorov J; Darai E
Gynecol Obstet Fertil; 2014 Sep; 42(9):585-90. PubMed ID: 24993654
[TBL] [Abstract][Full Text] [Related]
2. [An analysis of breast cancer treatment waiting times: Experience of a tertiary referral center in Morocco].
Mimouni M; Chaouki W; Errihani H; Benjaafar N
Bull Cancer; 2018 Sep; 105(9):755-762. PubMed ID: 30005892
[TBL] [Abstract][Full Text] [Related]
3. [Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012].
Pourcel G; Ledesert B; Bousquet PJ; Ferrari C; Viguier J; Buzyn A
Bull Cancer; 2013 Dec; 100(12):1237-50. PubMed ID: 24158562
[TBL] [Abstract][Full Text] [Related]
4. [One day diagnosis for breast lesions: Medical and psychological assessment--EVADIASEIN study].
Berman A; Teig B; Duracinsky M; Gayet M; Bellin MF; Guettier C; Fernandez H; Nazac A
J Gynecol Obstet Biol Reprod (Paris); 2016 Jan; 45(1):21-8. PubMed ID: 25724597
[TBL] [Abstract][Full Text] [Related]
5. Oncoplastic surgery in surgical treatment of breast cancer: is the timing of adjuvant treatment affected?
Dogan L; Gulcelik MA; Karaman N; Ozaslan C; Reis E
Clin Breast Cancer; 2013 Jun; 13(3):202-5. PubMed ID: 23103367
[TBL] [Abstract][Full Text] [Related]
6. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico].
Arce-Salinas C; Lara-Medina FU; Alvarado-Miranda A; Castañeda-Soto N; Bargalló-Rocha E; Ramírez-Ugalde MT; Pérez-Sánchez V; Rivera L; Gambo-Vignole C; Santamaría-Galicia J; Nieves-Casas RI; Morán-Muñoz H; Mohar-Betancourt A
Rev Invest Clin; 2012; 64(1):9-16. PubMed ID: 22690524
[TBL] [Abstract][Full Text] [Related]
8. Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04.
Rayson D; Saint-Jacques N; Younis T; Meadows J; Dewar R
CMAJ; 2007 Jan; 176(3):327-32. PubMed ID: 17261829
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis impact of breast cancer adjuvant radiotherapy delay].
Lesage M; Pilloy J; Fleurier C; Cirier J; Jourdan ML; Arbion F; Body G; Ouldamer L
Gynecol Obstet Fertil Senol; 2019 Jun; 47(6):516-521. PubMed ID: 30851415
[TBL] [Abstract][Full Text] [Related]
10. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.
Oh JL; Dryden MJ; Woodward WA; Yu TK; Tereffe W; Strom EA; Perkins GH; Middleton L; Hunt KK; Giordano SH; Oswald MJ; Domain D; Buchholz TA
J Clin Oncol; 2006 Nov; 24(31):4971-5. PubMed ID: 17075114
[TBL] [Abstract][Full Text] [Related]
11. Immediate reconstruction after neoadjuvant chemotherapy: effect on adjuvant treatment starting and survival.
Gouy S; Rouzier R; Missana MC; Atallah D; Youssef O; Barreau-Pouhaer L
Ann Surg Oncol; 2005 Feb; 12(2):161-6. PubMed ID: 15827797
[TBL] [Abstract][Full Text] [Related]
12. [Indication of radiotherapy after neoadjuvant chemotherapy in breast cancer].
Selz J; Le Scodan R; Ménard J; Hennequin C; Quero L
Cancer Radiother; 2014 Jun; 18(3):229-34. PubMed ID: 24819247
[TBL] [Abstract][Full Text] [Related]
13. Factors delaying chemotherapy for breast cancer in four urban and rural oncology units.
Fox PN; Chatfield MD; Beith JM; Allison S; Della-Fiorentina S; Fisher D; Turley K; Grimison PS
ANZ J Surg; 2013 Jul; 83(7-8):533-8. PubMed ID: 22984845
[TBL] [Abstract][Full Text] [Related]
14. [Treatment patterns and affecting factors in breast cancer patients over 65-years of age].
Mao Y; Chen X; Gao W; Liu J; Shen K
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):366-71. PubMed ID: 25030593
[TBL] [Abstract][Full Text] [Related]
15. [Determinants of patient and health system delays for women with breast cancer in Morocco, 2013].
Benbakhta B; Tazi M; Benjaafar N; Khattabi A; Maaroufi A
Rev Epidemiol Sante Publique; 2015 Jun; 63(3):191-201. PubMed ID: 25975777
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer and neoadjuvant therapy: any predictive marker?
Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France.
Laas E; Vataire AL; Aballea S; Valentine W; Gligorov J; Chereau E; Rouzier R
J Med Econ; 2012; 15(6):1167-75. PubMed ID: 22853442
[TBL] [Abstract][Full Text] [Related]
18. [Role of diagnostic imaging of the breast in patients treated with postsurgical radiotherapy or presurgical radiotherapy or chemotherapy].
Bock E; Bock C; Belli P; Campioni P; Manfredi R; Pastore G
Radiol Med; 1998; 95(1-2):38-43. PubMed ID: 9636725
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of occult breast cancer: report of 23 cases].
Zhong Y; Sun Q; Huang HY; Zhou YD; Guan JH; Mao F; Lin Y; Xu YL
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):716-8. PubMed ID: 21122392
[TBL] [Abstract][Full Text] [Related]
20. [Axillary support in breast cancer: survey practice in France].
Barranger E; Houvenaeghel G; Classe JM
Gynecol Obstet Fertil; 2013; 41(7-8):433-6. PubMed ID: 23856585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
